Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) FCF Margin (2018 - 2025)

TransMedics (TMDX) has 8 years of FCF Margin data on record, last reported at 47.58% in Q4 2025.

  • For Q4 2025, FCF Margin fell 6238.0% year-over-year to 47.58%; the TTM value through Dec 2025 reached 31.56%, up 2097.0%, while the annual FY2025 figure was 31.56%, 2097.0% up from the prior year.
  • FCF Margin reached 47.58% in Q4 2025 per TMDX's latest filing, up from 18.83% in the prior quarter.
  • Across five years, FCF Margin topped out at 109.96% in Q4 2024 and bottomed at 174.71% in Q4 2023.
  • Average FCF Margin over 5 years is 37.8%, with a median of 31.09% recorded in 2023.
  • Peak YoY movement for FCF Margin: tumbled -19079bps in 2023, then skyrocketed 28467bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 101.63% in 2021, then soared by 116bps to 16.08% in 2022, then plummeted by -1186bps to 174.71% in 2023, then skyrocketed by 163bps to 109.96% in 2024, then tumbled by -57bps to 47.58% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 47.58% in Q4 2025, 18.83% in Q3 2025, and 74.61% in Q2 2025.